The Harvard Drug
3 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for The Harvard Drug and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-07-01FDA-DrugClass IIMajor Pharmaceuticals Methylergonovine Maleate recalled for subpotency
MAJOR Pharmaceuticals is recalling Methylergonovine Maleate Tablets, USP, 0.2 mg due to subpotency — meaning the tablets contain less active ingredient than labeled. The affected lots were distributed nationwide. This is a prescription medication used to control bleeding after childbirth.
- 2026-04-22FDA-DrugClass IIStop using recalled memantine hydrochloride capsules
Major Pharmaceuticals is recalling memantine hydrochloride extended-release 7 mg capsules (lot N02425, expiring 05/31/2027) because the capsules may not dissolve properly in the body. This means the medication may not work as intended. The affected capsules were distributed nationwide.
- 2026-03-11FDA-DrugClass IICheck midodrine hydrochloride tablets for damaged packaging
Major Pharmaceuticals is recalling midodrine hydrochloride 5 mg tablets (Lot N02640, expiring 08/2027) because some blister packages are not properly sealed. Defective packaging could allow the medication to degrade or become contaminated. No injuries have been reported.
Get notified about new The Harvard Drug recalls
Free weekly digest. We email when a new federal recall affects The Harvard Drug or anything else in your household.
Get the Sunday Brief